mXELIRI
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for mXELIRI, covering 2021-09-05 to 2024-01-23. Get the full timeline:
Most recent: Clinical Trial Update: PD-1 Antibody Combined With mXELIRI Versus mXELIRI in the Second-line Setting for ESCC [Phase 3]